M.KirchnerH.YiC
After 16 weeks of liraglutide therapy, the patient achieved a 9.7 kg weight reduction, demonstrating that GLP-1 RAs can re-induce weight loss even after prior surgical failure [68]
In two single-arm, open-label clinical trials comprising 37 children with MLD, Lenmeldy significantly reduced the risk of severe motor impairment or death compared with untreated children, according to the FDAs press release
These agents include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), while tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
Small, frequent meals help achieve protein targets without overwhelming appetite suppression